BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
226 hedge funds and large institutions have $4.34B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2020 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 77 increasing their positions, 63 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
29% more funds holding
Funds holding: 175 → 226 (+51)
22% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 63
Holders
226
Holding in Top 10
16
Calls
$160M
Puts
$37.7M
Top Buyers
| 1 | +$71.7M | |
| 2 | +$41.3M | |
| 3 | +$41.1M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$39.9M |
| 5 |
SC
Samlyn Capital
New York
|
+$39.2M |
Top Sellers
| 1 | -$75.7M | |
| 2 | -$40.6M | |
| 3 | -$29M | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$25.4M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$21.7M |